MedPath

UNIVERSITY OF ALABAMA AT BIRMINGHAM

🇺🇸United States
Ownership
-
Established
1969-01-01
Employees
2K
Market Cap
-
Website
http://www.uab.edu

Efficacy of Topical Lidocaine to Decrease Discomfort With Intranasal Midazolam Administration

Not Applicable
Completed
Conditions
Pain
Interventions
First Posted Date
2015-03-24
Last Posted Date
2017-02-23
Lead Sponsor
University of Alabama at Birmingham
Target Recruit Count
77
Registration Number
NCT02396537

A Novel Neurorehabilitation Approach for Cognitive Aging With HIV

Not Applicable
Completed
Conditions
HIV
Aging
Interventions
Device: transcranial direct current stimulation (tDCS)
First Posted Date
2015-03-18
Last Posted Date
2017-05-15
Lead Sponsor
University of Alabama at Birmingham
Target Recruit Count
42
Registration Number
NCT02391311
Locations
🇺🇸

UAB 1917 Clinic, Birmingham, Alabama, United States

Influence of Ambient Temperature on Food Intake Through a Randomized Control Trial in an Office Setting

Not Applicable
Completed
Conditions
Food Intake in 2 Thermal Environments
Interventions
Other: Thermal Environment
First Posted Date
2015-03-12
Last Posted Date
2015-03-12
Lead Sponsor
University of Alabama at Birmingham
Target Recruit Count
20
Registration Number
NCT02386891
Locations
🇺🇸

University of Alabama at Birmingham School of Public Health, Birmingham, Alabama, United States

Randomized Controlled Trial of Higher-Volume Feedings in Preterm Neonates

Not Applicable
Completed
Conditions
Infant Premature
Interventions
Other: Higher Volume Feeding Goal
First Posted Date
2015-03-03
Last Posted Date
2018-06-18
Lead Sponsor
University of Alabama at Birmingham
Target Recruit Count
224
Registration Number
NCT02377050
Locations
🇺🇸

University of Alabama at Birmingham, Birmingham, Alabama, United States

Salpingectomy at Cesarean Delivery for Ovarian Cancer Reduction (SCORE)

Not Applicable
Completed
Conditions
Ovarian Cancer
Interventions
Procedure: Standard postpartum tubal ligation
Procedure: Complete Salpingectomy
First Posted Date
2015-03-02
Last Posted Date
2017-10-05
Lead Sponsor
University of Alabama at Birmingham
Target Recruit Count
80
Registration Number
NCT02374827
Locations
🇺🇸

University of Alabama at Birmingham, Birmingham, Alabama, United States

Preventing Sickle Cell Kidney Disease

Phase 2
Terminated
Conditions
Anemia, Sickle Cell
Sickle Cell Disease
Kidney Disease
Proteinuria
Hypertension
Interventions
First Posted Date
2015-02-26
Last Posted Date
2024-04-03
Lead Sponsor
University of Alabama at Birmingham
Target Recruit Count
1
Registration Number
NCT02373241
Locations
🇺🇸

University of Alabama at Birmingham, Birmingham, Alabama, United States

Verapamil for Beta Cell Survival Therapy in Type 1 Diabetes

Phase 2
Completed
Conditions
Type 1 Diabetes Mellitus
Interventions
Drug: Placebo
First Posted Date
2015-02-26
Last Posted Date
2020-02-05
Lead Sponsor
University of Alabama at Birmingham
Target Recruit Count
32
Registration Number
NCT02372253
Locations
🇺🇸

University of Alabama at Birmingham, Birmingham, Alabama, United States

Peripheral Blood Flow Responses to Electromagnetic Energy

Not Applicable
Recruiting
Conditions
Exposure to Man-made Visible Light
Interventions
Device: 670 nm light
Drug: octafluropropane
First Posted Date
2015-02-24
Last Posted Date
2025-04-01
Lead Sponsor
University of Alabama at Birmingham
Target Recruit Count
40
Registration Number
NCT02370199
Locations
🇺🇸

Medical College of Wisconsin, Milwaukee, Wisconsin, United States

Mechanisms of Refractory Hypertension (Carvedilol)

Not Applicable
Withdrawn
Conditions
Hypertensive
Interventions
First Posted Date
2015-02-06
Last Posted Date
2020-06-12
Lead Sponsor
University of Alabama at Birmingham
Registration Number
NCT02357004

Mechanisms of Refractory Hypertension (High and Low Salt Diet)

Not Applicable
Withdrawn
Conditions
Hypertension
Interventions
Dietary Supplement: NaCl tablets
First Posted Date
2015-02-06
Last Posted Date
2020-06-12
Lead Sponsor
University of Alabama at Birmingham
Registration Number
NCT02357017
© Copyright 2025. All Rights Reserved by MedPath